Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Inventory: 2016-2024

Historic Inventory for UroGen Pharma (URGN) over the last 7 years, with Dec 2024 value amounting to $9.2 million.

  • UroGen Pharma's Inventory rose 9.84% to $8.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year increase of 9.84%. This contributed to the annual value of $9.2 million for FY2024, which is 62.65% up from last year.
  • Per UroGen Pharma's latest filing, its Inventory stood at $9.2 million for FY2024, which was up 62.65% from $5.7 million recorded in FY2023.
  • UroGen Pharma's 5-year Inventory high stood at $9.2 million for FY2024, and its period low was $2.0 million during FY2020.
  • For the 3-year period, UroGen Pharma's Inventory averaged around $6.4 million, with its median value being $5.7 million (2023).
  • As far as peak fluctuations go, UroGen Pharma's Inventory skyrocketed by 146.03% in 2021, and later fell by 10.49% in 2022.
  • UroGen Pharma's Inventory (Yearly) stood at $2.0 million in 2020, then skyrocketed by 146.03% to $4.8 million in 2021, then decreased by 10.49% to $4.3 million in 2022, then soared by 31.17% to $5.7 million in 2023, then spiked by 62.65% to $9.2 million in 2024.